Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.580
-0.150 (-4.02%)
At close: Dec 5, 2025, 4:00 PM EST
3.561
-0.019 (-0.53%)
After-hours: Dec 5, 2025, 7:52 PM EST
Absci Employees
As of December 31, 2024, Absci had 157 total employees, including 156 full-time and 1 part-time employees. The number of employees increased by 1 or 0.64% compared to the previous year.
Employees
157
Change (1Y)
1
Growth (1Y)
0.64%
Revenue / Employee
$17,930
Profits / Employee
-$729,962
Market Cap
538.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 157 | 1 | 0.64% |
| Dec 31, 2023 | 156 | -37 | -19.17% |
| Dec 31, 2022 | 193 | -19 | -8.96% |
| Dec 31, 2021 | 212 | 110 | 107.84% |
| Dec 31, 2020 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABSI News
- 1 day ago - Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - GlobeNewsWire
- 1 day ago - 10 AI Stocks Worth Buying Right Now - The Motley Fool
- 14 days ago - Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 23 days ago - Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 5 weeks ago - Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - GlobeNewsWire
- 5 weeks ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial - GlobeNewsWire